AzTrials
AzTrials

Irreversible PulpitisNCT06240130

Outcome Following Use of NaOCl and Chlorhexidine as Wound Lavage Agents

A study testing Partial pulpotomy in people with Irreversible Pulpitis, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to to compare effect of wound lavage agents NaOCl and Chlorhexidine on the outcome of partial pulpotomy in mature permanent posterior teeth with signs and symptoms indicative of irreversible pulpitis in. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Irreversible Pulpitis
What is being tested?
Partial pulpotomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
142 participants
Where
1 siteIndia
Study dates
1 Jul 2022to 1 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Mature permanent mandibular posterior teeth with extreme deep caries and clinical diagnosis of symptomatic irreversible pulpitis
  • Patients having normal periapical status with periapical index (PAI) score ≤ 2 and periodontally healthy teeth
  • Patients having physical status of class 1 or 2 according to ASA classification
  • Pulpal bleeding can be controlled within 10 minutes

Who cannot join

  • Necrotic pulp upon exposure
  • Presence of sinus tract or soft tissue swelling Pregnant patients Radiographic signs of internal or external root resorption

Trial locations and contacts

1 site in 1 country.

India1 site
  • PGIDS

    Rohtak, Haryana, 124001

Other trials in India

About this study

Official title: Outcome Following Use of NaOCl and Chlorhexidine as Wound Lavage Agents During Partial Pulpotomy in Mature Permanent Teeth With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial

The goal of this clinical trial is to to compare effect of wound lavage agents NaOCl and Chlorhexidine on the outcome of partial pulpotomy in mature permanent posterior teeth with signs and symptoms indicative of irreversible pulpitis in.

The main question it aims to answer are:

Does wound lavage using chlorhexidine have equal effect as NaOCl on the outcome of partial pulpotomy in mature permanent mandibular posterior teeth with clinical signs of irreversible pulpitis?

Participants will of age group 18 to 45 years will be included and divided into two groups:

Pulp wound lavage in partial pulpotomy using 3% NaOCl as control and using 2% Chlorhexidine as experiment

Read the detailed description

Title- Outcome following use of NaOCl and chlorhexidine as wound lavage agents during partial pulpotomy in mature permanent teeth with symptomatic irreversible pulpitis: A randomized clinical trial Research Question Does wound lavage using chlorhexidine have equal effect as NaOCl on the outcome of partial pulpotomy in mature permanent mandibular posterior teeth with clinical signs of irreversible pulpitis? PICO

  • P (Population) - Mature permanent posterior teeth with clinical signs of symptomatic irreversible pulpitis
  • I (Intervention) - 2% Chlorhexidine lavage during Partial pulpotomy
  • C (Comparison) - 3% Sodium hypochlorite lavage during Partial pulpotomy
  • O (Outcome) -Assessment of clinical and radiographic success at 12 months follow up To evaluate reduction in post operative pain experience at every 24 hours till 1 week
  • T (time frame)- 18 months Aim-The aim of the study is to compare effect of wound lavage agents NaOCl and Chlorhexidine on the outcome of partial pulpotomy in mature permanent posterior teeth with signs and symptoms indicative of irreversible pulpitis.

Objective- Primary objective- To evaluate the clinical and radiographic success of partial pulpotomy using NaOCl or chlorhexidine as wound lavage agents in mature permanent posterior teeth with clinical signs and symptoms of irreversible pulpitis.

Secondary objective- To assess postoperative pain after partial pulpotomy using NaOCl or chlorhexidine wound lavage.

Setting: Dept. Of Conservative Dentistry \& Endodontics, PGIDS, Rohtak. FINER F (feasible)= Adequate number of subjects for sample size and technical expertise are available to conduct the study I (Interesting)= The study aims to compare the effect of lavage agents (NaOCl and Chlorhexidine) on the outcome of partial pulpotomy in patients diagnosed with symptomatic irreversible pulpitis N(Novel)= No clinical trial study has compared the effect of wound lavage agents on the outcome of partial pulpotomy in mature permanent mandibular posterior teeth E(Ethical)= Ethical issues have been taken care of during the planning of the study. Subjects will be provided with information sheet and consent form. Once the study is approved by the ethical committee of the institution, it will be conducted and followed up R (Relevant)= This study will help formulate evidence-based guidelines for use of different lavage agents during partial pulpotomy in mature permanent mandibular posterior teeth.

S= Specific- yes M= Measurable- yes A= Achievable- yes R= Relevant- yes T= Time frame- 18 months

Study subjects:

Subjects of age group 18 to 45 years will be included and divided into two groups:

Pulp wound lavage in partial pulpotomy using 3% NaOCl as control and using 2% Chlorhexidine as experiment Inclusion Criteria 1) Mature permanent mandibular posterior teeth with extreme deep caries and clinical diagnosis of symptomatic irreversible pulpitis 2) Patients having normal periapical status with periapical index (PAI) score ≤ 2 and periodontally healthy teeth 3) Patients having physical status of class 1 or 2 according to ASA classification 4) Pulpal bleeding can be controlled within 10 minutes Exclusion Criteria

  1. Necrotic pulp upon exposure
  2. Presence of sinus tract or soft tissue swelling
  3. Pregnant patients
  4. Radiographic signs of internal or external root resorption Sample Size The current study is planned as an equivalent study and sample size calculated using website software www.sealedenvelope.com, which revealed that a minimum of 39 participants will be required in each group. Considering 20% loss to follow up, 49 patients will be included per group.

Randomisation Study subjects will be stratified according to age and will be randomly allocated in equal proportion to either 3% NaOCl lavage or 2% Chlorhexidine lavage group using concealed envelopes to know whether the subject would receive NaOCl rinse or Chlorhexidine rinse.

PROCEDURE After pulp exposure, amputation of superficial pulpal tissue to a depth of 2-3 mm will be done using a sterile round bur in the high-speed handpiece.

The pulp wound will be irrigated

with 3% NaOCl in with 2% Chlorhexidine in control group experimental group

Haemostasis will be achieved by placing the cotton pellet soaked with 3% NaOCl and 2% chlorhexidine in respective groups

In both groups, MTA will be and will be placed to a thickness of 2-3 mm and a layer of RMGI liner will be placed over the MTA. Then the tooth will be permanently restored with composite resin followed by immediate post operative radiograph

FOLLOW UP Patient will be recalled after 1 week, 3 months, 6 months and 1 year for clinical evaluation. Radiographic evaluation will be done after 6 months and 1 year using the same digital imaging system with standard exposure parameters as used during immediate postoperative radiograph.

Outcome Measures Primary outcome- Clinical and radiographic success rate Secondary outcome- postoperative pain experience Pain Assessment Visual analogue scale (VAS) from 0 to 100 will be used to record preoperative and post -operative pain.

Clinical Success Criteria

  1. Absence of signs and symptoms of spontaneous pain or pain on stimulus and discomfort, soft tissue swelling, sinus or fistula
  2. No tenderness to palpation or percussion and no periodontal probing depth
  3. Positive response on EPT and cold testing Radiographic Success Criteria
  4. Periapical Index (PAI) score ≤ 2 according to Orstavick 2) Absence of internal or external root resorption Statistical analysis Statistical analysis will be done using suitable statistical method
Being tested
Partial pulpotomy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Partial pulpotomyProcedure or surgery

    after caries removal and pulp exposure pulp tissue is amputated and wound lavage done with 3% NaOCl in partial pulpotomy

  • Partial pulpotomyProcedure or surgery

    after caries removal and pulp exposure pulp tissue is amputated and wound lavage done with 2% Chlorhexidine in partial pulpotomy

Study groups in NCT06240130
Study groupRoleWhat they receive
Sodium hypochlorite lavage groupActive comparator3% sodium hypochlorite lavage will be done after pulp amputation
Receives: Procedure: Partial pulpotomy
Chlorhexidine lavage groupExperimental2% Chlorhexidine lavage will be done after pulp amputation
Receives: Procedure: Partial pulpotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Success and Radiographic Success

    CLINICAL SUCCESS CRITERIA:

    Absence of spontaneous pain, discomfort, swelling, sinus tract or tenderness to palpation or percussion.

    RADIOGRAPHIC SUCCESS CRITERIA:

    No pathosis evident on the radiograph such as root resorption, furcal pathosis or new periapical pathosis.

    Periapical Index score 1 or 2 according to Orstavic et al.

    Evaluation of both clinical and radiographic outcome is must for analyzing the actual success of therapeutic technique. Number of participants fulfilling both clinical as well as radiographic success criteria will be considered in success category.

    Measured: Base line to 12 months

Secondary outcomes (1)
  1. Post operative pain

    To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line. Score 0 means no pain and Score 100 means maximum pain To assess incidence and intensity of pain postoperatively at every 24 hours till 7 days using Visual analogue Scale of 0 to 100 millimeter line. Score 0 means no pain and Score 100 means maximum pain

    Measured: Base line to 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2024
  2. Study start1 Jul 2022
  3. Primary completion1 Mar 2023
  4. Study completion1 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
142 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06240130
Sponsor's protocol ID
Soumyashree Mishra
Status last verified
Aug 2024
First submitted
13 Jan 2024
Last updated
16 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Mishra S, Sangwan P, Duhan J, Arora M, Mittal S, Kumar V, Ramani A. Outcome of Partial Pulpotomy in Mature Permanent Molars After Lavage With Chlorhexidine or Sodium Hypochlorite: A Randomised Clinical Trial. Int Endod J. 2026 Jan;59(1):80-90. doi: 10.1111/iej.70043. Epub 2025 Sep 30.

    PubMed 41026352

Questions about this trial

What is this clinical trial studying?

A study testing Partial pulpotomy in people with Irreversible Pulpitis, run by Postgraduate Institute of Dental Sciences Rohtak at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Success and Radiographic Success (time frame: Base line to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06240130, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in